S763-0509 Screening compound: N-benzyl-9-oxo-11-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]-tetradecahydrocyclopenta[b]1,5-diazacycloundecane-1-carboxamide

S763-0509 Screening compound: N-benzyl-9-oxo-11-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]-tetradecahydrocyclopenta[b]1,5-diazacycloundecane-1-carboxamide
S763-0509 Screening compound: N-benzyl-9-oxo-11-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]-tetradecahydrocyclopenta[b]1,5-diazacycloundecane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S763-0509
N-benzyl-9-oxo-11-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]-tetradecahydrocyclopenta[b]1,5-diazacycloundecane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S763-0509

Molecular Formula

C27H32N6O3 (C27 H32 N6 O3)

Compound Name

N-benzyl-9-oxo-11-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]-tetradecahydrocyclopenta[b]1,5-diazacycloundecane-1-carboxamide

IUPAC name

(9aR11R12aS)-N-benzyl-9-oxo-11-[3-(pyridin-3-yl)-124-oxadiazol-5-yl]-tetradecahydrocyclopenta[b]15-diazacycloundecane-1-carboxamide

SMILES

O=C(NCc1ccccc1)N(CCCCCCN1)[C@@H](C[C@@H](C2)c3nc(-c4cnccc4)no3)[C@@H]2C1=O

InChI

InChI=1S/C27H32N6O3/c34-25-22-15-21(26-31-24(32-36-26)20-11-8-12-28-18-20)16-23(22)33(14-7-2-1-6-13-29-25)27(35)30-17-19-9-4-3-5-10-19/h3-5,8-12,18,21-23H,1-2,6-7,13-17H2,(H,29,34)(H,30,35)/t21-,22+,23-/m0/s1

InChI Key

DZLOUAFUZKVUQB-ZRBLBEILSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

488.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.292

Distribution Coefficient, logD

2.653

Water Solubility, LogSw

-3.13

Polar Surface Area

92.941

Acid Dissociation Constant (pKa)

13.33

Base Dissociation Constant (pKb)

7.93

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

44.44

S763-0509 in Drug Discovery

Included in Screening Libraries

Macrocycles Library (2450 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with S763-0509 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S763-0509?
Check Price and Availability of S763-0509, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S763-0509 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S763-0509
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S763-0509
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S763-0509 available by request